GERD Can Induce Occurrence of Rheumatoid Arthritis, but Not Vice Versa

31 Jan 2024
www.drugs.com
Clinical Result
WEDNESDAY, Jan. 31, 2024 -- Gastroesophageal reflux disease (GERD) causally and positively influences rheumatoid arthritis (RA), but RA has no significant influence on GERD, according to a study published online Dec. 13 in Frontiers in Genetics.
Haifan Wang, from The Second Affiliated Hospital of Xi'an Jiaotong University in China, and colleagues examined the bidirectional causal effects between GERD and RA by two-sample Mendelian randomization (MR) analyses using genetic evidence for 129,080 GERD cases versus 602,604 controls and 6,236 RA cases and 147,221 controls. The primary analysis used an inverse-variance weighted method.
The researchers found valid evidence provided by both univariate (UV)MR and multivariate (MV)MR analyses that RA was causally and positively influenced by GERD (odds ratios, 1.49 and 1.69 for UVMR and MVMR, respectively), but RA did not influence GERD.
"The results suggested that GERD can induce the occurrence of RA, whereas RA has no significant impact on GERD," the authors write. "In particular, individuals with GERD are at a 69 percent higher risk of developing RA, highlighting GERD as a significant risk factor for this condition."
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.